{
    "2019-09-20": [
        [
            {
                "time": "",
                "original_text": "药明康德(02359.HK)完成回购及注销2018年A股激励计划项下部分限制性A股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "回购",
                        "注销",
                        "2018年A股激励计划",
                        "限制性A股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "美迪西招股书多项数据遭质疑，明日能否顺利过会？",
                "features": {
                    "keywords": [
                        "美迪西",
                        "招股书",
                        "数据质疑",
                        "过会"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}